TEL
AVIV Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums.
Not exact matches
TEL
AVIV, May 2 -
Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums.
TEL
AVIV, May 2 (Reuters)-
Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums.